Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.8.0.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net loss $ (6,281) $ (3,218)
Research and development-licenses acquired, expensed 75 575
Issuance of common shares - Founders Agreement 0 1,232
Stock-based compensation expenses 1,995 0
Depreciation expense 7 0
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (731) (15)
Interest receivable (97) 0
Accounts payable and accrued expenses (787) (117)
Payable and accrued expenses - related party 179 (110)
Accrued interest - related party 0 (411)
Deferred rent 75 0
Notes payable - related party 0 28
Net cash used in operating activities (5,565) (2,036)
Cash Flows from Investing Activities:    
Purchase of short-term investment (certificates of deposit) (25,000) 0
Maturity of certificate of deposit 14,000 0
Purchase of research and development licenses (75) (375)
Purchase of fixed assets - construction-in-process (676) 0
Net cash used in investing activities (11,751) (375)
Cash Flows from Financing Activities:    
Payment of Fortress Note 0 (320)
Proceeds from issuance of common stock and warrants, net of offering cost of $0 and $5,663, respectively 0 50,242
Proceeds from exercise of warrants 96 0
Net cash provided by financing activities 96 49,922
Net change in cash, cash equivalents and restricted cash (17,220) 47,511
Cash, cash equivalents and restricted cash, beginning of the period 35,475 27,499
Cash, cash equivalents and restricted cash, end of the period 18,255 75,010
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 413
Supplemental disclosure of noncash investing and financing activities:    
Construction-in-progress included in accounts payable and accrued expenses 2,320 0
Issuance of common shares - Founders Agreement 9,558 4,396
Common shares issuable for license acquired $ 0 $ 1,682